Rett syndrome from bench to bedside: recent advances [version 1; referees: 2 approved]
Rett Syndrome is a severe neurological disorder mainly due to de novo mutations in the methyl-CpG-binding protein 2 gene (MECP2). Mecp2 is known to play a role in chromatin organization and transcriptional regulation. In this review, we report the latest advances on the molecular function of Mecp2 a...
Main Authors: | Yann Ehinger, Valerie Matagne, Laurent Villard, Jean-Christophe Roux |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2018-03-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/7-398/v1 |
Similar Items
-
Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome
by: Yann Ehinger, et al.
Published: (2021-04-01) -
A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome
by: Valerie Matagne, et al.
Published: (2017-03-01) -
Development of trofinetide for the treatment of Rett syndrome: from bench to bedside
by: Melissa Kennedy, et al.
Published: (2024-01-01) -
Recent advances in dermoscopy [version 1; referees: 2 approved]
by: Teresa Russo, et al.
Published: (2016-02-01) -
Recent advances in bronchoscopy [version 1; referees: 2 approved]
by: Elaine Dumoulin
Published: (2018-10-01)